Nike’s China Reset Will Take 4 Quarters — Wall Street Is Done Waiting

Photo of Joel South
By Joel South Published

Quick Read

  • Goldman Sachs and JPMorgan downgraded Nike (NKE) to Neutral with $52 price targets, citing an extended turnaround timeline with China recovery now not expected until fiscal 2029 as local brands gain share and consumer spending cools.

  • Nike’s forward P/E of 44x implies a near-term earnings recovery that contradicts the Street’s own updated guidance showing negative sales momentum extending into Q4 and flat EPS for the next nine months, making the current valuation increasingly disconnected from fundamentals.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Nike’s China Reset Will Take 4 Quarters — Wall Street Is Done Waiting

© 24/7 Wall St.

Nike (NYSE:NKE | NKE Price Prediction) stock is absorbing a wave of analyst downgrades and price target cuts following fiscal Q3 results, which the company reported on March 31. The stock fell 14.44% in early trading on Wednesday to around $45.22. The central message from Wall Street is consistent: The China recovery will take longer than expected, and the patience required to hold through it has a limit.

So far this year, shares of NKE are down 28.54%, dragging Nike stock down 30.17% over the past 52 weeks.

Ticker Company Firm Action Old Rating New Rating Old Target New Target
NKE Nike Goldman Sachs Downgrade Buy Neutral $76 $52
NKE Nike JPMorgan Downgrade Overweight Neutral $86 $52
NKE Nike BofA Downgrade Buy Neutral $73 $55
NKE Nike Barclays Price Target Cut Overweight Overweight $73 $67
NKE Nike BTIG Price Target Cut Buy Buy $90 $75
NKE Nike Citi Price Target Cut Neutral Neutral $65 $53
NKE Nike Piper Sandler Price Target Cut Overweight Overweight $75 $60
NKE Nike Stifel Price Target Cut Hold Hold $65 $56
NKE Nike Truist Price Target Cut Buy Buy $69 $57

The Analyst’s Case

Goldman Sachs and JPMorgan both downgraded Nike to Neutral with a $52 price target, while BofA moved to Neutral from Buy with a $55 target. The common thread: the turnaround timeline has been extended materially. Management guided sales to remain negative into Q3, with EPS expected to be roughly flat for the next nine months. JPMorgan’s timeline for Nike reaching a 10% operating margin has now been pushed to fiscal 2029, from fiscal 2028.

China is the sharpest pain point. Q4 Greater China revenues are expected to decline 20%, extending a streak that has now run six consecutive quarters. Local brands including Anta and Li Ning are gaining share, and cooling consumer spending is compounding the pressure.

Company Snapshot

Nike reported fiscal Q4 revenue of $11.28B, with Greater China coming in at $1.615B, down 7% reported and -10% currency-neutral. Gross margin contracted to 40%, down 130 basis points year-over-year, pressured by tariff headwinds in North America. EPS of 35 cents beat the 28 cent-estimate, but net income fell 35% year-over-year, partly reflecting a normalized tax rate. CEO Elliott Hill’s “Win Now” initiative is ongoing, with restructuring continuing through year-end.

Why the Move Matters Now

The stock sits well below both its 50-day moving average of $59.93 and 200-day moving average of $66.70. The forward P/E of 44x implies significant earnings recovery is already priced in, yet quarterly earnings growth is running at -32% year-over-year. That disconnect is precisely what the downgrade wave is pricing out. The analyst consensus target of $74.97 still sits well above current levels, but the three downgrades suggest that target is being actively reassessed across the Street.

What It Means for Your Portfolio

Nike’s 3.63% dividend yield and 24 consecutive years of dividend increases remain a legitimate anchor for income-focused holders. But the China reset is now a multi-year story, and management’s own guidance frames the near-term as a continued drag. The current valuation implies a recovery that, by Wall Street’s own updated models, may not fully materialize until fiscal 2029.

Photo of Joel South
About the Author Joel South →

Joel South covers large-cap stocks, dividend investing, and major market trends, with a focus on earnings analysis, valuation, and turning complex data into actionable insights for investors.

He brings more than 15 years of experience as an investor and financial journalist, including 12 years at The Motley Fool, where he served as an investment analyst, Bureau Chief, and later led the Fool.com investing news desk. He has also co-hosted an investing podcast and appeared across TV and radio discussing market trends.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618